Erratum: Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women
2002
Correction on Goserelin's Role in Early Breast Cancer
Editorial
Author Information
Author(s): Jonat W
Primary Institution: Department of Obstetrics and Gynecology, University of Kiel
Conclusion
The chemotherapy regimen for the ECOG/SWOG/CALGB INT-0101 study was incorrectly presented and has been corrected.
Supporting Evidence
- The chemotherapy regimen for the ECOG/SWOG/CALGB INT-0101 study was incorrectly presented.
- The corrected version of the figure is now provided.
Takeaway
There was a mistake in a study about a breast cancer treatment, and it has now been fixed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website